pageInfo({
    time : "1261193306318"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "UKTRE56B21R20090712"
	        , headline : "Study may prompt rethink on schizophrenia drugs"
	        , keywords : "[Healthcare, Pharmaceuticals - generic and speciality, Living and lifestyle, Pharmaceuticals - diversified, Western Europe, Europe, Online Report text item, United Kingdom, Pharmaceuticals (sub-industry), Switzerland, Pharmaceuticals and biotechnology, Health and medicine, United States of America, Central and Eastern Europe, Art, Hobbies, Canada]"
	        , tickers : "[AZN.L, JNJ.N, LLY.N, mx;JNJ, mx;LLY, NOVN.VX, us;AZN, us;AZNC, us;AZND, us;JNJ, gb;LELZ, gb;LEL, gb;AZNX, ch;JNJ, ch;LLY, ch;NOV, de;JNJ, de;JNJF, de;JNJS, de;LLY, gb;AZN, gb;AZND, us;LLY]"
	    }
	    , channel : {
	        id : "54"
	        , name : "companyNews"
	        , title : "Company News"
	    }})